Stevanato Group S.p.A. (NYSE:STVN) Given Average Recommendation of “Hold” by Analysts

Shares of Stevanato Group S.p.A. (NYSE:STVN) have been assigned an average recommendation of “Hold” from the five analysts that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and three have assigned a buy recommendation to the company.

STVN has been the topic of several research analyst reports. Weiss Ratings downgraded Stevanato Group from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, March 11th. Citigroup decreased their target price on Stevanato Group from $32.00 to $26.00 and set a “buy” rating for the company in a research report on Thursday, March 5th. Wall Street Zen cut Stevanato Group from a “buy” rating to a “hold” rating in a research report on Saturday, February 14th. Jefferies Financial Group set a $17.50 price target on Stevanato Group in a research note on Tuesday, February 10th. Finally, KeyCorp decreased their price objective on Stevanato Group from $37.00 to $32.00 and set an “overweight” rating for the company in a report on Thursday, March 5th.

Stevanato Group Stock Performance

Shares of STVN stock opened at €18.66 on Friday. The firm has a market cap of $5.65 billion, a price-to-earnings ratio of 31.63, a P/E/G ratio of 1.66 and a beta of 0.75. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.11 and a current ratio of 1.63. Stevanato Group has a 52 week low of €12.89 and a 52 week high of €28.00. The firm’s 50-day simple moving average is €15.93 and its two-hundred day simple moving average is €17.96.

Stevanato Group (NYSE:STVN) last released its earnings results on Friday, May 8th. The company reported €0.11 earnings per share for the quarter, missing analysts’ consensus estimates of €0.12 by (€0.01). Stevanato Group had a net margin of 11.76% and a return on equity of 10.27%. The company had revenue of €273.57 million for the quarter. During the same period in the prior year, the company earned $0.10 earnings per share. The firm’s revenue for the quarter was up 6.6% on a year-over-year basis. As a group, equities analysts forecast that Stevanato Group will post 0.68 earnings per share for the current year.

Hedge Funds Weigh In On Stevanato Group

Large investors have recently modified their holdings of the business. Conestoga Capital Advisors LLC raised its position in shares of Stevanato Group by 7.6% in the first quarter. Conestoga Capital Advisors LLC now owns 8,491,751 shares of the company’s stock valued at $116,762,000 after purchasing an additional 602,050 shares during the period. Fideuram Intesa Sanpaolo Private Banking S.P.A. bought a new position in Stevanato Group in the 4th quarter worth approximately $9,269,000. Norges Bank purchased a new position in Stevanato Group in the 4th quarter valued at approximately $8,185,000. Credit Agricole S A purchased a new position in Stevanato Group in the 3rd quarter valued at approximately $9,785,000. Finally, T. Rowe Price Investment Management Inc. raised its holdings in Stevanato Group by 10.4% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 3,923,632 shares of the company’s stock valued at $78,944,000 after acquiring an additional 368,792 shares during the period.

Stevanato Group Company Profile

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.